| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |